isoxazoles has been researched along with Glioma in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Darabi, A; Eberstål, S; Fritzell, S; Sandén, E; Siesjö, P; Visse, E | 1 |
Bae, YS; Jo, SH; Kim, SD; Lee, HJ; Lee, HY; Lee, SY; Shim, JW; Yun, J | 1 |
Aguilar, HR; Bachoo, RM; Frantz, DE; Hsieh, J; Hsu, T; Li, P; Schneider, JW; Zhang, L | 1 |
Bae, YS; Chang, YJ; Han, M; Im, DS; Kim, HL; Kim, K; Kim, YL; Lee, YK; Okajima, F; Sacket, SJ | 1 |
Han, M; Im, DS; Jo, JY; Kim, HL; Kim, K; Kim, YL; Lee, YK; Sacket, SJ | 1 |
Chang, YJ; Im, DS; Jo, JY; Kim, HL; Kim, YL; Kyeok, K | 1 |
Conti, P; Dallanoce, C; De Amici, M; De Micheli, C; Klotz, KN | 1 |
Berens, ME; Chen, H; Chu, L; Germain, L; Hersh, E; Hirth, KP; Jacobs, JS; Longhi, M; Mann, E; McMahon, G; Meredith, S; Powell, TJ; Schwartz, DP; Shawver, LK; Tang, C; Taylorson, L; Tsai, J; Ullrich, A | 1 |
Blinder, L; Chong, AS; Huang, W; Mall, JW; Myers, JA; Saclarides, TJ; Shen, J; Williams, JW; Xu, X | 1 |
9 other study(ies) available for isoxazoles and Glioma
Article | Year |
---|---|
Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Synergism; Female; Flow Cytometry; Glioma; Granulocyte-Macrophage Colony-Stimulating Factor; Immunoenzyme Techniques; Immunotherapy; Intramolecular Oxidoreductases; Isoxazoles; Mice; Mice, Inbred C57BL; Prostaglandin-E Synthases; Sulfonamides; Tumor Cells, Cultured | 2014 |
Lysophosphatidylserine stimulates chemotactic migration in U87 human glioma cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Chemotaxis; Glioma; Humans; Isoxazoles; JNK Mitogen-Activated Protein Kinases; Lysophospholipids; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Propionates; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid | 2008 |
Small-molecule blocks malignant astrocyte proliferation and induces neuronal gene expression.
Topics: Animals; Astrocytes; Cell Dedifferentiation; Cell Proliferation; Cells, Cultured; Cellular Reprogramming; Epigenesis, Genetic; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glioma; Histone Deacetylase Inhibitors; Isoxazoles; Mice; Neoplastic Stem Cells; Neurogenesis; Neurons; Thiophenes; Tumor Suppressor Proteins | 2011 |
Dioleoyl phosphatidic acid increases intracellular Ca2+ through endogenous LPA receptors in C6 glioma and L2071 fibroblasts.
Topics: Animals; Calcium; Cell Line, Tumor; Dose-Response Relationship, Drug; Fibroblasts; Gene Expression; Glioma; Isoxazoles; Lysophospholipids; Mice; Pertussis Toxin; Phosphatidic Acids; Propionates; Rats; Receptors, Lysophosphatidic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2007 |
Lysophosphatidylserine induces calcium signaling through Ki16425/VPC32183-sensitive GPCR in bone marrow-derived mast cells and in C6 glioma and colon cancer cells.
Topics: Animals; Bone Marrow Cells; Calcium Signaling; Colonic Neoplasms; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrenes; Glioma; HCT116 Cells; Humans; Inositol 1,4,5-Trisphosphate Receptors; Isoxazoles; Lysophospholipids; Male; Mast Cells; Mice; Mice, Inbred BALB C; Organophosphates; Pertussis Toxin; Propionates; Pyridines; Pyrrolidinones; Rats; Receptors, Lysophosphatidic Acid; Time Factors; Type C Phospholipases | 2008 |
Dioleoyl phosphatidic acid induces morphological changes through an endogenous LPA receptor in C6 glioma cells.
Topics: Animals; Cell Line, Tumor; Cell Survival; Cytotoxins; Drug Partial Agonism; Glioma; Isoproterenol; Isoxazoles; Lysophospholipids; Organophosphates; Pertussis Toxin; Phosphatidic Acids; Propionates; Pyridines; Rats; Receptors, Lysophosphatidic Acid | 2008 |
Synthesis of new delta 2-isoxazoline derivatives and their pharmacological characterization as beta-adrenergic receptor antagonists.
Topics: Adenylyl Cyclases; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; CHO Cells; Chromatography, Thin Layer; Cricetinae; Glioma; Humans; Isoxazoles; Magnetic Resonance Spectroscopy; Pindolol; Propanolamines; Radioligand Assay; Rats; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Tumor Cells, Cultured | 1998 |
Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Topics: 3T3 Cells; Animals; Brain Neoplasms; Cell Survival; Epidermal Growth Factor; Female; Glioma; Growth Inhibitors; Humans; Isoxazoles; Leflunomide; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Ovarian Neoplasms; Platelet-Derived Growth Factor; Prostatic Neoplasms; Rats; Receptor, Platelet-Derived Growth Factor beta; Receptors, Platelet-Derived Growth Factor; Recombinant Proteins; Signal Transduction; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |
In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action.
Topics: 3T3 Cells; Adjuvants, Immunologic; Aniline Compounds; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Crotonates; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Glioma; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Nitriles; Phosphorylation; Pyrimidine Nucleotides; Receptors, Growth Factor; Receptors, Platelet-Derived Growth Factor; Toluidines; Tumor Cells, Cultured; Tyrosine | 1999 |